Patent US5498238A successfully refreshed from Google Patents.
US5498238A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Simultaneous angioplasty and phoretic drug delivery
Assignee: Mmc/gatx Partnership No1
•
Filing: 1993-08-27
•
Granted: 1996-03-12
•
Expires: 2013-08-27
Abstract
Abstract A method of simultaneous angioplasty and drug delivery to a localized portion of coronary or peripheral arteries or any other type of body passage that has a stricture. The invention contemplates positioning a drug delivery device in a body passageway and then selectively introducing a selected drug so that the device is expanded in order to dilate the passage and then simultaneously causing the drug to be transported across a drug transport wall of the device for direct contact with the passageway wall. A more specific aspect of the present invention involves treating a dilated vessel in the area of a stenotic lesion with a fixative or other drug to render the vessel biologically inert and to form a biological stent or prevent restenosis using specifically selected drugs.
Inventors
- 👤 James E. Shapland
- 👤 Mark B. Knudson
- 👤 Jin Shimada
- 👤 Joel R. Racchini
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:18
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/10; A61M25/104; A61M16/00; A61M16/04; A61M16/0434; A61M16/0443; A61M16/0454; A61M16/0456; A61M16/0475; A61M16/0477; A61M16/0481; A61M37/00; A61M37/0092; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/05; A61N1/18; A61N1/20; A61N1/30; A61N1/303; A61N1/306; A61N1/32; A61N1/325; A61M16/0486; A61M25/0043; A61M2025/0057; A61M2025/1043; A61M2025/105; A61N1/056; A61N2001/0585
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
152 words
A method for simultaneously performing percutaneous translumenal coronary angioplasty and delivering a drug to a localized area of a passageway with a catheter having a proximal end, a distal end, and a balloon operably connected to the distal end, wherein the balloon has a single chamber and a plurality of pores having a diameter of about 1 μor less, the method comprising the steps of: a) advancing the catheter through the passageway until the balloon is adjacent to the localized area; b) injecting a fluid through an injection lumen in the catheter and into the single chamber of the balloon causing the balloon to inflate to a pressure of about 2 atmospheres or more and apply a pressure against the localized area of the passageway thereby dilating the localized area of the passageway; and c) phoretically transporting the drug to the localized area while simultaneously dilating the localized area of the passageway.
Claim 2
Independent Claim
152 words
A method for simultaneously performing percutaneous translumenal coronary angioplasty and delivering a drug to a localized area of a passageway with a catheter having a proximal end, a distal end, and a balloon operably connected to the distal end, wherein the balloon has a single chamber and a plurality of pores having a diameter of about 1 μor less, the method comprising the steps of: a) advancing the catheter through the passageway until the balloon is adjacent to the localized area; b) injecting a fluid through an injection lumen in the catheter and into the single chamber of the balloon causing the balloon to inflate to a pressure of about 2 atmospheres or more and apply a pressure against the localized area of the passageway thereby dilating the localized area of the passageway; and c) phoretically transporting the drug to the localized area while simultaneously dilating the localized area of the passageway.
Claim 3
Dependent Claim
23 words
The method of claim 1 wherein the step of transporting the drug is performed while the localized area of the passageway is dilated.
Claim 4
Dependent Claim
38 words
The method of claim 1 wherein the drug comprises at least a portion of the fluid and further wherein the step of transporting the drug further comprises transporting the drug through a selectively permeable portion of the balloon.
Claim 5
Dependent Claim
29 words
The method of claim 3 wherein the step of transporting the drug through a selectively permeable portion of the balloon further comprises transporting the drug through a microporous membrane.
Claim 6
Dependent Claim
37 words
The method of claim 4 wherein the step of transporting the drug through a microporous membrane further comprises passing the drug through pores in the microporous membrane that have a size between 0.05 μ and 1.0 μ.
Claim 7
Dependent Claim
25 words
The method of claim 3 further comprising the step of withdrawing at least a portion of the fluid from the chamber through a recovery lumen.
Claim 8
Dependent Claim
38 words
The method of claim 6 wherein the step of injecting the fluid further comprises injecting the fluid into the chamber and withdrawing the fluid from the chamber at a rate that maintains the balloon in an inflated state.
Claim 9
Dependent Claim
29 words
The method of claim 7 wherein the step of transporting the drug through a selectively permeable portion of the balloon further comprises transporting the drug through a microporous membrane.
Claim 10
Dependent Claim
36 words
The method of claim 8 wherein the step of transporting the drug through a microporous membrane further comprises passing the drug through pores in the microporous membrane that have a size between 0.05 μand 1.0 μ.
Claim 11
Dependent Claim
34 words
The method of claim 3 wherein the step of transporting the drug through a selectively permeable portion of the balloon further comprises phonophoretically transferring the drug through the selectively permeable portion of the balloon.
Claim 12
Dependent Claim
35 words
The method of claim 3 wherein the step of phoretically transporting the drug through a selectively permeable portion of the balloon further comprises iontophoretically transferring the drug through the selectively permeable portion of the balloon.
Claim 13
Dependent Claim
27 words
The method of claim 11 wherein the step of iontophoretically transferring the drug further comprises passing a wave form of electrical pulses through the selectively permeable portion.
Claim 14
Dependent Claim
31 words
The method of claim 1 further comprising the step of coating a portion of an outer surface of the balloon with a gel before the catheter is advanced through the passageway.
Claim 15
Dependent Claim
37 words
The method of claim 13 wherein the gel contains the drug and the step of transporting the drug to the localized area further comprises transferring the drug from the gel to the localized area of the passage.
Claim 16
Dependent Claim
31 words
The method of claim 1 further comprising the step of coating a portion of an inner surface of the balloon with a gel before the catheter is advanced through the passageway.
Claim 17
Dependent Claim
32 words
The method of claim 15 wherein the step of transporting the drug further comprises passing the fluid from the chamber, through the gel, and through a selectively permeable portion of the balloon.
References Cited (Backward Citations)
US578611A
Cited
US725731A
Cited
US873021A
Cited
US2123980A
Cited
US2499045A
Cited
US3542014A
Cited
US3865108A
Cited
JPS49132888A
Cited
US4126134A
Cited
CH588870A5
Cited
US4202346A
Cited
US4137906A
Cited
US4323071A
Cited
US4323071B1
Cited
CH645273A5
Cited
DD147314A1
Cited
US4551132A
Cited
SU1003853A1
Cited
US4608984A
Cited
US4403612A
Cited
US4338942A
Cited
US4383529A
Cited
US4364392A
Cited
US4416274A
Cited
US4411648A
Cited
US4509523A
Cited
US4610662A
Cited
US4573966A
Cited
US4456012A
Cited
US4417576A
Cited
US4636195A
Cited
US4606337A
Cited
SU1146057A1
Cited
SU1069826A1
Cited
SU1069827A1
Cited
US4693704A
Cited
US4714460A
Cited
US4582181A
Cited
US4689041A
Cited
US4705507A
Cited
JPS6160729A
Cited
US4824436A
Cited
US4663358A
Cited
FR2582946A1
Cited
US4698058A
Cited
US4776337A
Cited
US4733665C2
Cited
US4776337B1
Cited
US4733665B1
Cited
US4733665A
Cited
US4832688A
Cited
SU1410973A1
Cited
US4767402A
Cited
US4948587A
Cited
US4744366A
Cited
US4800882A
Cited
US4787888A
Cited
EP0299698A1
Cited
US4819637A
Cited
US4819751A
Cited
US5000734A
Cited
WO1989007194A1
Cited
US4866050A
Cited
EP0372088A1
Cited
US5232444A
Cited
US5087244A
Cited
US5047028A
Cited
EP0399712A1
Cited
US4994033A
Cited
US5007897A
Cited
US5041107A
Cited
US5236413A
Cited
US5236413B1
Cited
WO1991016945A1
Cited
WO1991019529A1
Cited
US5087243A
Cited
US5102402A
Cited
US5284486A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-03-12 | 1999-09-11 | 2000-03-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-03-12 | 2003-09-11 | 2004-03-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-03-12 | 2007-09-11 | 2008-03-12 | $7700.00 | Window Closed / Lapsed |